Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trial of Accelerated Adjuvant Chemotherapy With Capecitabine in Early Breast Cancer (TACT2)

NCT00301925 is registered in ClinicalTrials.gov with Institute of Cancer Research, United Kingdom as lead sponsor.

NCT NCT00301925
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00301925 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trial of Accelerated Adjuvant Chemotherapy With Capecitabine in Early Breast Cancer (TACT2)
Lead sponsor
Institute of Cancer Research, United Kingdom
Phase
Phase 3
Overall status
Unknown status
Start date
December 16, 2005
Completion date
September 30, 2024
Enrollment
4,400 (estimated)
Sites
152

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer